Fisher Investments: $3B Strategic Partnership with Advent, ADIAby Mark Eisenberg 16.06.2024Advent and ADIA invest $2.5-$3B, valuing Fisher Investments at $12.75B. Founder Ken Fisher sells holdings. New board member: Advent's Mussafer.
Nexalin Technology vs. Rivals: Volatility & Ownership Insightsby Mark Eisenberg 16.06.2024Nexalin Technology: 0.7% institutional, 7% insider ownership. Beta of 5.13 reveals high volatility; rivals surpass in 8 of 10 factors. ...
Weibo vs. Trump Media: Volatility & Risk Comparisonby Mark Eisenberg 16.06.2024Weibo's beta of 0.24 shows lower volatility compared to Trump Media's beta of 6.14. Weibo, founded in 2009, has 3% ...
CDTG vs. PESI: Which Environmental Stock Performs Better?by Mark Eisenberg 16.06.2024Perma-Fix Environmental outperforms CDT Environmental in 6 of 10 factors. Based in Atlanta, insiders hold 1% of Perma-Fix shares.
Elon Musk Allegedly Holds Major Dogecoin Stake: Hoskinsonby John Darbie 15.06.2024Charles Hoskinson suggests Musk potentially owns Dogecoin; lacks Tesla CEO's interest. Join Cointribune's 'Read to Earn' for crypto rewards.
Options Solutions & Major Firms Up Stakes in Micron Techby Terry Bingman 15.06.2024FMR LLC, Wellington Management, Morgan Stanley increased stakes in Micron Tech; insiders sold 372,446 shares, stock opened at $141.36, down ...
Prairie Operating’s Stephen Lee Sells $6,977 in Sharesby Mark Eisenberg 15.06.2024Prairie Operating's Lee sold shares at $10.98-$12.85; new RSUs granted. Transactions disclosed via SEC Form 4. More details on T&C ...
The Bitcoin Show: Simple Guide to Safely Storing Cryptocurrencyby John Darbie 15.06.2024A breakdown of crypto storage types: hot wallets (online), cold wallets (offline), and custodial wallets (managed by third parties, online ...
Schwab Exec Sells $600K+ in Stock, Exercises Optionsby Mark Eisenberg 15.06.2024Charles Schwab Corp. faces near-term challenges like 2% cash outflows in May; Goldman Sachs maintains Neutral rating with a $75.00 ...
Avidity Biosciences CFO Sells $3.7M in Stock Amid Positive Newsby Terry Bingman 15.06.2024Avidity Biosciences sees share ownership shift as MacLean reduces holding under Rule 10b5-1 Plan; positive sector developments bolster outlook.